Prem Watsa portfolio, Q1 2025
Fairfax Financial · 13F for the quarter ending Mar 31, 2025
For Q1 2025, Fairfax Financial reported $1.8B across 29 US-listed positions, led by Orla Mining Ltd (28.6%), OXY (16.1%) and CVS (10.0%). Compared with its filing for Q4 2024, Prem Watsa opened 1 new position, added to 3, reduced 2 and sold out of 3; 23 positions did not change.
The largest purchase was an addition to CLF ($74M); the largest sale, the sale of the whole position in TFII ($1.8M).
Key facts
- 13F portfolio value
- $1.8BQ1 2025
- Positions
- 29
- Largest holding
- Orla Mining Ltd 28.6%
- New positions
- 1
- Sold out
- 3
- Filed
- May 15, 2025
Holdings as of (Q1 2025), filed with the SEC on . Changes are measured against the filing for Dec 31, 2024. Every tracked investor's Q1 2025 13F.
Bought and sold in Q1 2025
| Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|
| Cleveland-Cliffs IncCLF | ▲ Added 153% | +9M | $74M | 4.01% |
| Tfi International IncTFII | ▼ Sold out | −13.3K | $1.8M | 0.10% |
| Kraft Heinz CoKHC | ▲ Added 1.4% | +45K | $1.4M | 0.07% |
| Molson Coors Beverage CoTAP | ▲ Added 1.7% | +20K | $1.2M | 0.07% |
| Xeris Biopharma Holdings IncXERS | ▼ Sold out | −139.69K | $472.1K | 0.03% |
| Lifeway Foods IncLWAY | ▲ New | +17.37K | $424.6K | 0.02% |
| KKR & Co. IncKKR | ▼ Reduced 15% | −3.5K | $404.6K | 0.02% |
| Colliers International Group IncCIGI | ▼ Reduced 12% | −3K | $353.3K | 0.02% |
Revance Therapeutics Incno ticker on file | ▼ Sold out | −21.16K | $64.1K | 0.00% |
Holdings at the quarter's end
| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| 1 | Orla Mining Ltdno ticker on file | — | 28.6% | $527M | 56.82M | $9.28 | 3+ qtrs | No change |
| 2 | Occidental Petroleum CorpOXY | Energy | 16.1% | $297.4M | 6.02M | $49.40 | 3+ qtrs | No change |
| 3 | CVS Health CorpCVS | Health Care | 9.96% | $183.8M | 2.71M | $67.76 | 2 qtrs | No change |
| 4 | Blackberry LtdBB | Technology | 9.52% | $175.7M | 46.72M | $3.76 | 3+ qtrs | No change |
| 5 | Cleveland-Cliffs IncCLF | Materials | 6.64% | $122.5M | 14.9M | $8.22 | 2 qtrs | ▲ Added 153% |
| 6 | Kennedy-Wilson Holdings Incno ticker on file | — | 6.26% | $115.5M | 13.32M | $8.67 | 3+ qtrs | No change |
| 7 | Kraft Heinz CoKHC | Consumer Staples | 5.54% | $102.2M | 3.36M | $30.42 | 3+ qtrs | ▲ Added 1.4% |
| 8 | Molson Coors Beverage CoTAP · CL B | Consumer Staples | 3.98% | $73.5M | 1.21M | $60.89 | 2 qtrs | ▲ Added 1.7% |
| 9 | Ats CorpATS | — | 3.29% | $60.8M | 2.49M | $24.44 | 3+ qtrs | No change |
| 10 | Under Armour IncUAA · CL A | — | 2.14% | $39.4M | 6.31M | $6.24 | 3+ qtrs | No change |
| 11 | Taiwan Semiconductor Manufacturing Company LtdTSM · SPONSORED ADS | Technology | 1.28% | $23.5M | 141.7K | $165.94 | 3+ qtrs | No change |
| 12 | Helmerich & Payne IncHP | — | 1.10% | $20.2M | 774.11K | $26.11 | 3+ qtrs | No change |
| 13 | General Motors CoGM | Consumer Discretionary | 0.96% | $17.7M | 375.97K | $47.01 | 3+ qtrs | No change |
| 14 | Bank of Nova ScotiaBNS | Financials | 0.92% | $17M | 359.1K | $47.41 | 3+ qtrs | No change |
| 15 | Pfizer IncPFE | Health Care | 0.89% | $16.5M | 650.9K | $25.33 | 3+ qtrs | No change |
| 16 | Merck & Co. IncMRK | Health Care | 0.84% | $15.5M | 172.9K | $89.69 | 3+ qtrs | No change |
| 17 | Johnson & JohnsonJNJ | Health Care | 0.66% | $12.2M | 73.4K | $165.88 | 3+ qtrs | No change |
| 18 | Micron Technology IncMU | Technology | 0.38% | $7M | 80K | $86.88 | 3+ qtrs | No change |
| 19 | Franco Nev CorpFNV | Materials | 0.14% | $2.6M | 16.8K | $156.99 | 3+ qtrs | No change |
| 20 | Colliers International Group IncCIGI · SUB VTG SHS | Real Estate | 0.14% | $2.6M | 22K | $117.77 | 3+ qtrs | ▼ Reduced 12% |
| 21 | Garrett Motion IncGTX | — | 0.14% | $2.5M | 304.36K | $8.37 | 3+ qtrs | No change |
| 22 | KKR & Co. IncKKR | Financials | 0.13% | $2.3M | 20K | $115.61 | 3+ qtrs | ▼ Reduced 15% |
| 23 | Gentex CorpGNTX | — | 0.11% | $2M | 85K | $23.29 | 3+ qtrs | No change |
| 24 | Capri Holdings LimitedCPRI · SHS | — | 0.08% | $1.5M | 78.1K | $19.73 | 3+ qtrs | No change |
| 25 | Autohome IncATHM · SP ADS RP CL A | — | 0.08% | $1.5M | 54K | $27.69 | 3+ qtrs | No change |
| 26 | MGM Resorts InternationalMGM | Consumer Discretionary | 0.05% | $874.7K | 29.5K | $29.65 | 3+ qtrs | No change |
| 27 | Berkshire Hathaway IncBRK-A · CL A | — | 0.04% | $798.4K | 1 | $798,442.00 | 3+ qtrs | No change |
| 28 | Magnachip Semiconductor CorpMX | — | 0.02% | $428.8K | 125K | $3.43 | 3+ qtrs | No change |
| 29 | Lifeway Foods IncLWAY | — | 0.02% | $424.6K | 17.37K | $24.45 | 1 qtr | New |
By sector
| Sector | Share of portfolio | Value | Positions |
|---|---|---|---|
| Energy | 16.1% | $297.4M | 1 |
| Health Care | 12.4% | $227.9M | 4 |
| Technology | 11.2% | $206.1M | 3 |
| Consumer Staples | 9.52% | $175.6M | 2 |
| Materials | 6.78% | $125.1M | 2 |
| Financials | 1.05% | $19.3M | 2 |
| Consumer Discretionary | 1.01% | $18.5M | 2 |
| Real Estate | 0.14% | $2.6M | 1 |
| No sector on file | 41.9% | $772.1M | 12 |
Questions and answers
What did Prem Watsa own in Q1 2025?
Fairfax Financial's 13F for Q1 2025 lists 29 positions worth $1.8B. The largest: Orla Mining Ltd (28.6%), OXY (16.1%), CVS (10.0%), BB (9.5%), CLF (6.6%).
What did Prem Watsa buy in Q1 2025?
The largest purchases, by the shares bought at the quarter-end price the filing implies: CLF (added, $74M), KHC (added, $1.4M), TAP (added, $1.2M), LWAY (new, $424.6K).
What did Prem Watsa sell in Q1 2025?
The largest sales: TFII (sold out, $1.8M), XERS (sold out, $472.1K), KKR (reduced, $404.6K), CIGI (reduced, $353.3K), Revance Therapeutics Inc (sold out, $64.1K).
When was this filing made?
Fairfax Financial filed its 13F for the quarter ending Mar 31, 2025 on May 15, 2025. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.
Learn
Cite this page
Funkfolio, “Prem Watsa portfolio, Q1 2025: Fairfax Financial 13F holdings”, data as of 15 May 2025. https://funkfolio.com/gurus/prem-watsa/2025-q1
Underlying data: SEC EDGAR, Form 13F-HR of Fairfax Financial (CIK 915191) for the period ending Mar 31, 2025.
Source: SEC EDGAR, Form 13F-HR for Fairfax Financial (CIK 915191), period ending Mar 31, 2025, filed May 15, 2025. Changes compare share counts with the filing for Dec 31, 2024; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $1.8B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 3 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.